药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Spectinomycin
Indalpine
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Indalpine.
Spectinomycin
Levomilnacipran
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Levomilnacipran.
Spectinomycin
Desvenlafaxine
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Desvenlafaxine.
Spectinomycin
Milnacipran
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Milnacipran.
Spectinomycin
Sibutramine
The risk or severity of adverse effects can be increased when Sibutramine is combined with Midomafetamine.
Spectinomycin
Seproxetine
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Seproxetine.
Spectinomycin
Dapoxetine
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Dapoxetine.
Spectinomycin
Zimelidine
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Zimelidine.
Spectinomycin
Tedizolid phosphate
Tedizolid phosphate may increase the hypertensive activities of Midomafetamine.
Spectinomycin
(S)-Warfarin
The risk or severity of adverse effects can be increased when Midomafetamine is combined with (S)-Warfarin.
Spectinomycin
Tioclomarol
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Tioclomarol.
Spectinomycin
Diphenadione
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Diphenadione.
Spectinomycin
Clorindione
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Clorindione.
Spectinomycin
Fluindione
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Fluindione.
Spectinomycin
Ethyl biscoumacetate
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Ethyl biscoumacetate.
Spectinomycin
(R)-warfarin
The risk or severity of adverse effects can be increased when Midomafetamine is combined with (R)-warfarin.
Spectinomycin
Coumarin
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Coumarin.
Spectinomycin
4-hydroxycoumarin
The risk or severity of adverse effects can be increased when Midomafetamine is combined with 4-hydroxycoumarin.
Spectinomycin
Phenprocoumon
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Phenprocoumon.
Spectinomycin
Naxitamab
The risk or severity of hypertension can be increased when Midomafetamine is combined with Naxitamab.